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Autophagy is a highly conserved catabolic process essential for embryonic development and adult ho-
meostasis. The autophagic machinery supplies energy by recycling intracellular components and facili-
tates the removal of apoptotic cells. In the inner ear, autophagy has been reported to play roles during
early development in the chicken embryo and in the response to otic injury in the adult mouse. However,
there are no studies on the expression of the autophagy machinery in the postnatal and adult inner ear.
Insulin-like growth factor 1 (IGF-1) is one of the factors that regulate both otic development and cochlear
postnatal maturation and function. Here, we hypothesised that autophagy could be one of the processes
involved in the cochlear development and functional maturation.
We report that autophagy-related genes (ATG) Becn1, Atg4g and Atg5 are expressed in the mouse
cochlea, vestibular system and brainstem cochlear nuclei from late developmental stages to adulthood.
Atg9 was studied in the mouse cochlea and showed a similar pattern. The presence of autophagic ﬂux
was conﬁrmed by decreased sequestosome 1 (SQSTM1/p62) and increased relative levels of microtubule-
associated protein light chain 3-II (LC3-II). Inner ear autophagy ﬂux is developmentally regulated and is
lower at perinatal stages than in the adult mouse, where an expression plateau is reached at the age of
two-months, coinciding with the age at which full functional activity is reached. Expression is main-
tained in adult mice and declines after the age of twelve months. LC3B labelling showed that autophagy
was primarily associated with spiral ganglion neurons. Over time, Igf1 wild type mice showed lower
expression of genes coding for IGF-1 high afﬁnity receptor and the family factor IGF-2 than null mice.
Parallel analysis of autophagy machinery gene expression showed no signiﬁcant differences between the
genotypes over the lifespan of the null mice. Taken together, these results show that the autophagy
machinery expression in the inner ear is regulated with age but is not compromised by the chronic
absence of IGF-1. Our data also strongly support that the up-regulation of autophagy machinery genes is
concomitant with the functional maturation of the inner ear.
This article is part of a Special Issue entitled <IEB Kyoto>.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).x2, cyclooxygenase 2; IGF-I,
ated protein 1 light chain 3;
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B.V. This is an open access article u1. Introduction
Autophagy is a highly conserved lysosomal degradation
pathway in eukaryotes that is responsible for providing metabolic
energy, recycling intracellular components and eliminating dele-
terious molecules and organelles. Autophagy protects cells from
several regular and pathological stresses and it plays a fundamental
role during development and in the maintenance of adult cellular
homeostasis. Accordingly, autophagy dysfunction is associated
with ageing, neurodegenerative diseases and in tumour suppres-
sion (Lopez-Otin et al., 2013; Schneider and Cuervo, 2014).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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autophagy, microautophagy and macroautophagy, the latter of
which is the subtype studied here and henceforth called autophagy
(Aburto et al., 2012a). Autophagy is generally considered non-
speciﬁc, but it may also be a selective process for degrading
damaged or unnecessary organelles, molecules and pathogens
(Reggiori and Ungermann, 2012). Autophagy is triggered by
different inductive signals that initiate formation of the phag-
ophore. This consists of a double lipid membrane that initially
engulfs cytoplasmic proteins or organelles. Later it expands and
encloses the cytoplasmic cargo to form the autophagosome and
ﬁnally, it fuses with the lysosome, leading to cargo degradation by
hydrolytic enzymes. Nucleotides, amino acids and fatty acids are
products from this catabolic process, which are returned through
permeases to the cytosol to be reused in the synthesis of macro-
molecules and in ATP generation (Hurley and Schulman, 2014).
Several stages can be identiﬁed in the process: induction, nucle-
ation or assembly, elongation and autophagosome completion.
Each stage has been associated with the induction of a speciﬁc
subset of Atg, which is evolutionarily conserved from yeast to
humans (Klionsky et al., 2003). The Beclin1 and ULK1/2 complex
plays a part in the induction of the autophagosome where ULK1
activates the phosphatidylinositol 3-kinase (PI3KC). The ATG9
cycling system transports membranes from several donor sources
and is essential for autophagosome formation (Aburto et al., 2012a).
ATG9 has been reported to be transcriptionally regulated in
numerous contexts (Jin et al., 2014). Two ubiquitin-like conjugation
systems, ATG12 and ATG8, are involved in elongation of the auto-
phagosome membrane. The ATG12 complex is composed of ATG5,
ATG7, ATG10, ATG12 and ATG16L1 proteins, while ATG8 is made up
of ATG3, ATG4A/B/C/D, ATG7 and LC3A/B/B2/C, as well as GABARAP/
l1/l2/GATE-16 (Le Grand et al., 2011). Both complexes regulate LC3,
the mammalian Atg8 homolog. The ATG4B protease is responsible
for breaking down the LC3 C-terminal residue, generating the
cytosolic form, LC3-I. Due to the action of ATG7, ATG3 and ATG16L1,
LC3-I is conjugated to phosphatidylethanolamine to generate LC3-II
that remains bound to the autophagosomal membrane (Feng et al.,
2014a). The relative levels of LC3-II combined with the lysosomal
degradation of autophagic substrates are readouts of autophagic
ﬂux. The SQSTM1/p62 protein binds to LC3-I and to ubiquitinated
protein aggregates and facilitates their entry into the autophago-
some. Therefore, degradation of SQSTM1/p62 is dependent on
autophagy and its levels are negatively correlated with those of
LC3-II (Bjorkoy et al., 2006, 2009; Klionsky et al., 2008).
During embryonic development, autophagy is a key dynamic
catabolic process highly regulated by hormonal and environmental
signals. Developmental autophagy provides energy to neonates and
promotes remodelling of different cells and tissues (Aburto et al.,
2012a), the developing nervous system being one of them (Fimia
et al., 2007). Autophagy induction has been reported to resolve
inﬂammation, to ameliorate ageing and to protect from neuro-
degeneration (Menardo et al., 2012; Nixon, 2013; Rubinsztein et al.,
2011). Autophagy has an essential role in adult neurons, where it
contributes to homeostasis by removing harmful protein aggre-
gates and damaged organelles. Thus adult neurons exhibit high
basal rates of autophagy that are further up-regulated upon neu-
rodegeneration (Son et al., 2012). This cytoprotective role is so
important that autophagy has been proposed as an essential pro-
cess for the determination of mammalian lifespan (Lopez-Otin
et al., 2013).
The adult inner ear is responsible for the detection of sound in
the cochlea and for the sense of equilibrium in the vestibule
(Magarinos, 2014; Magarinos et al., 2012). Both have a commondevelopmental origin in the otic placode, an ectodermal structure
that closes up to form the otic vesicle from which most cells of the
adult inner ear are formed (Magarinos et al., 2012; Sanchez-
Calderon et al., 2007). This includes the auditory spiral neurons
that connect the sensory hair cells at the organ of Corti with the
central auditory pathway whose ﬁrst relay station is the cochlear
nucleus complex (Magarinos et al., 2012). A number of earlier re-
ports have shown the presence of autophagy in the inner ear of
several species. Thus, Atg4b/ null mice show aberrant equilibrium
due to a defect in the development of the vestibular otoconia
(Marino et al., 2010). Autophagy is also involved in neurogenesis of
the chicken vestibular and auditory spiral ganglion (Aburto et al.,
2012b) which requires the proliferation and differentiation of otic
progenitors as well as apoptosis (Aburto et al., 2012b; Magarinos
et al., 2010). Autophagy provides energy for the removal of
apoptotic cells. Moreover, autophagic morphological features are
present in adult hair cells exposed to ototoxic insults (Taylor and
Kirkegaard, 2008).
IGF-1 is a trophic factor for the developing and adult nervous
system that belongs to the insulin family. Mutations in its coding
gene, IGF1, cause human syndromic deafness (Murillo-Cuesta et al.,
2011). Igf1/ null mice also show sensorineural hearing loss pri-
marily caused by failure in late differentiation concomitant with
increased apoptosis of mouse spiral neurons (Camarero et al., 2002,
2001; Sanchez-Calderon et al., 2010). Several studies have linked
IGF-1 with autophagy although, depending on the cellular context,
it shows distinct actions. IGF-1 decreases autophagy in mammary
epithelial cells through activation of mTOR (Sobolewska et al.,
2009). On the other hand, in cultures of Purkinje neurons, IGF-1
promotes autophagy by inducing fusion of autophagosomes with
lysosomes (Bains et al., 2009). Correspondingly, inhibition of
downstream insulin signalling and IGF-1 receptors decreases the
number of autophagosomes both in cell cultures and in vivo (Renna
et al., 2013). This reduction is caused by endocytosis defects, a
process involved in providing membrane substrate to form auto-
phagosomal precursors (Renna et al., 2013).
In this work, we show that autophagy machinery expression is
regulated in the inner ear from late embryonic E18.5 develop-
mental stages to nine month-old adult mice. Unexpectedly, at the
ages studied, there were no striking differences between cochlear
expression of ATGs in wild type and null Igf1/ mice. Autophagic
ﬂux reaches a plateau in cochlea at the age of two months, coin-
ciding with mouse functional maturity, when autophagic proteins
are abundantly present in the neurons of the spiral ganglia.
2. Materials and methods
2.1. Mouse handling and genotyping
Heterozygous mice with targeted disruption of the Igf1 gene
were bred and maintained on a hybrid MF1 and 129/sv mouse
genetic background to increase Igf1/ mutant survival (Liu et al.,
1993). Postnatal survival of null mice varied between 10 and 20%,
less than a 5% survived to one year (Riquelme et al., 2010). No
differences betweenmale and female micewere observed and both
were used in this study. Concretely, male wild type and null mice
numbers were: 5 and 8 of P30e60, 5 and 3 of P90, 3 and 1 of P150, 7
and 8 of P270, and 3 and 1 of P365, respectively. Female wild type
and null mice used in this study were: 8 and 6 of P30e60, 2 and 1 of
P90, 1 and 2 of P150, 8 and 7 of P270, and 0 and 3 of P365,
respectively.
Mice genotypes were determined as described (Sanchez-
Calderon et al., 2010). Animal care procedures and use were
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procedures were conducted in accordance with European Union
(2010/63/EU) and Spanish R&D (53/2013) legislations.
2.2. Transcriptome analysis of the cochlea by GeneChip arrays
Cochleae from E18.5 Igf1þ/þ and Igf1/mice were dissected and
RNA isolated from two mice was pooled. The cochlear expression
proﬁle was analysed in triplicate using GeneChip® Mouse Genome
430A2.0 Array (Affymetrix, Santa Clara, CA) as described previously
(Sanchez-Calderon et al., 2010). Results were submitted to the
public functional genomics data repository GEO (Gene Expression
Omnibus, http://www.ncbi.nlm.nih.gov/geo/) with accession
number GSE11821. The free software package PUMA (http://www.
bioconductor.org) was used to estimate gene expression levels of
GeneChip array data. Gene expression was further analysed by a
combination of fold change (FC) and PPLR (Probability of Positive
Log Ratio) methods.
2.3. Quantitative RT-PCR
RNA was isolated using RNeasy (Qiagen) from frozen cochleae,
vestibule and brain homogenates. When indicated, cochlear nuclei
were dissected and used to isolate RNA. Their integrity and con-
centration were assessed using an Agilent Bioanalyzer 2100 (Agi-
lent Technologies). 3e6 mice from each genotype of the following
ages were used: embryonic day E18.5 and postnatal days P30e60,
P150, P270 and P365. cDNA was then generated by reverse tran-
scription (High Capacity cDNA Reverse Transcription Kit;
Applied Biosystems) and gene expression was analysed in
triplicate samples by qPCR using TaqMan® Gene Expression Assay
kits (Applied Biosystems). The following probes (Life Technologies)
were used: Atg4b (Mm01701111_m1), Atg5 (Mm00504340_m1),
Atg9a (Mm01264420_m1), Becn1 (Mm01265461_m1),
Cox2 (Mm03294838_g1), Igf1r (Mm00802831_m1), Igf2
(Mm00439564_m1) and Ins2 (Mm00731595_gH). PCR was per-
formed on an Applied Biosystems 7900HT Real-Time PCR System
using eukaryotic 18S and Rplp0 rRNA as the endogenous house-
keeping genes with the same results. Relative quantiﬁcation values
were calculated using the 2DDCt method and the data were
expressed as mean log10RQ values (Rodriguez-de la Rosa et al.,
2014).
2.4. Protein extraction and Western blotting
Proteins from E18.5, P30e60 and P270 frozen cochleae, vesti-
bule and brain homogenates from 3 to 6 mice/experimental group
were extracted using a Ready Protein Extraction Kit (BioRad) as
reported (de Iriarte Rodriguez et al., 2015). Each tissue was lysed in
100e250 ml extraction buffer containing 0.01% protease- and
phosphatase-inhibitor cocktails and 0.01% TBP (Sigma Aldrich).
Protein concentration was determined using the RC DC Protein
Assay kit (BioRad) with bovine serum albumin (BSA) as the stan-
dard. Equal amounts of proteins were subjected to gel electro-
phoresis (10% kD Mini-PROTEAN-TGX, BioRad) and transferred to
PVDF membranes (0.2-mm, BioRad) using a Bio-Rad Trans Blot
TURBO apparatus. After incubation with a blocking solution, the
membranes were probed overnight (4 C) with primary antibodies
(anti b-actin, 1:5000, Sigma/A5441; anti LC3, 1:1000, MBL/PD014;
and, anti SQSTM1/p62, 1:1000, MBL/PM045). Membranes were
then incubated with a peroxidase-conjugated secondary antibody
for 1 h (RT), and the bands were visualized using Clarity™Western
ECL Substrate (BioRad/170e5060). Blot imageswere captured usingan ImageQuant LAS4000 mini digital camera (GE Healthcare Bio-
Sciences), and densities of the immunoreactive bands were quan-
tiﬁed by densitometry using ImageQuant TL software (GE Health-
care Bio-Sciences). Different exposure times were used to ensure
that bands were not saturated.
2.5. Histology and immunohistochemistry
E18.5 and P30e90 cochleae were dissected and ﬁxed overnight
in 4% paraformaldehyde in PBS (4 C), decalciﬁed in 0.3 M EDTA (pH
6.5) for 8 days and embedded in gelatin. Cryosections (10 mm) were
incubated with the primary antibody (anti-LC3B, 1:100, Cell Sig-
nalling/2775; anti-Sox2, 1:50, Santa Cruz/sc-17320) overnight
(4 C) and then with Alexa Fluor-conjugated secondary antibody
(Donkey-anti-rabbit IgG (AF488), 1:300, Life Technologies/A21206;
Donkey-anti-goat IgG (AF546),1:300, Life Technologies/A11056) for
2 h (RT). Sections were mounted in Prolong Gold containing DAPI
(Invitrogen/P36931) and visualized using a ﬂuorescence micro-
scope (Nikon 90i) and confocal microscope (LSM710 Zeiss). LC3B
immunoﬂuorescence intensity in the spiral ganglion was deter-
mined in 4e12 equivalent sections prepared from at least 3 mice of
each genotype and age. Quantiﬁcations were performed in a region
of interest (ROI) in each cochlea from base to apex using ImageJ
software (National Institutes of Health, Bethesda, MD, USA). All
ﬁgures were assembled using Adobe Photoshop CS4.
2.6. Statistical analysis
In order to compare gene expression in the organs, time points
and genotypes were studied using a three-way Multivariate Anal-
ysis of Variance (MANOVA) and followed up with pairwise Stu-
dent's t-tests to isolate the signiﬁcant effects of individual levels.
Multiple comparison post hoc analyses included the Bonferroni test
when equal variances were assumed to exist. All statistical analyses
were performed using SPSS v19.0 software (SPSS Inc., Chicago, IL,
USA). Data were expressed as mean values ± SEM. Results were
considered signiﬁcant at p < 0.05.
3. Results
3.1. Autophagy gene transcripts are expressed in the E18.5 mouse
cochlea
Autophagy gene expression in E18.5 cochlea was studied in
Igf1þ/þ and Igf1/ mice using RNA arrays as reported [GEO num-
ber: GSE11821; (Sanchez-Calderon et al., 2010); Table 1]. Genes
involved in autophagic processes were selected and categorized
using previously published data (Chen and Klionsky, 2011; Feng
et al., 2014b; Gordy and He, 2012; Klionsky, 2005; Mizushima,
2007; Rubinstein and Kimchi, 2012). Most genes showed no
expression differences among genotypes (Table 1A and B), but
Ndp52, Tlr1 and Tlr6 transcripts did. Ndp52 is decreased in the co-
chlea of Igf1/ deﬁcient mouse and it plays an important role in
immunity by modulating autophagy. NDP52 is an autophagy re-
ceptor for ubiquitin-coated pathogens with the ability to bind LC3
and ubiquitylated cargo simultaneously (Kraft et al., 2010; Thurston
et al., 2009). Tlr1 and Tlr6 are members of the toll-like receptor
(TLR) family that have a key role in the innate immune system (Shi
and Kehrl, 2008; Yordy et al., 2013). RNA array data showed
increased Tlr1 and decreased Tlr6 expression in the Igf1/ mouse
cochlea when compared to wild type ones, whereas expression of
other members of the TLR family was unmodiﬁed. Activation of
TLR1 throughMydD88, alongwith othermembers of the TLR family
Table 1
Comparative expression levels of autophagy genes in the cochlea of E18.5 Igf1þ/þ and Igf1/ mice.
Gene symbol Gene Igf1þ/þ expression Igf1/ expression Fold change
A. Genes of the autophagy machinery
Genes involved in autophagosome formation
Atg12 Autophagy-related 12 (yeast) 5.41 5.36 0.053
Atg16l1 Autophagy-related 16-like 1 (yeast) 7.44 7.44 0.002
Atg4b Autophagy-related 4B (yeast) 7.09 7.09 0.001
Atg4d Autophagy-related 4D (yeast) 5.42 5.39 0.023
Atg5 Autophagy-related 5 (yeast) 6.79 6.79 0.001
Becn1 Beclin 1 7.16 7.16 0.006
Gabarap Gaba receptor associated protein 10.95 10.95 0.003
Gabarapl1 Gaba receptor-associated protein-like 1 8.46 8.45 0.004
Gabarapl2 Gaba receptor-associated protein-like 2 8.25 8.24 0.016
Map1lc3a Microtubule-associated protein 1lc3a 9.81 9.81 0.001
Rgs19 Regulator of G-protein signalling 19 7.20 7.10 0.104
Ulk1 Unc-51 like kinase 1 (C. elegans) 6.28 6.22 0.057
Genes responsible for autophagic transport
Atg10 Autophagy-related 10 (yeast) 6.19 6.19 0.006
Atg16l1 Autophagy-related 16-like 1 (yeast) 7.44 7.44 0.002
Atg3 Autophagy-related 3 (yeast) 4.54 4.49 0.051
Atg4b Autophagy-related 4B (yeast) 7.09 7.09 0.001
Atg4d Autophagy-related 4D (yeast) 5.42 5.39 0.023
Atg7 Autophagy-related 7 (yeast) 4.39 4.41 0.027
Gabarap Gaba receptor associated protein 10.95 10.95 0.003
Gabarapl2 Gaba receptor-associated protein-like 2 8.25 8.24 0.016
Rab24 RAB24, member RAS oncogene family 7.65 7.54 0.109
Genes responsible for autophagosome-lysosome/vacuole fusion
Gabarap Gaba receptor associated protein 10.95 10.95 0.003
Lamp1 Lysosomal membrane glycoprotein 1 10.51 10.51 0.003
Npc1 Niemann Pick type C1 7.70 7.70 0.005
Genes involved in autophagy and ubiquination
Bag3 Bcl2-associated athanogene 3 7.35 7.12 0.233
Atg7 Autophagy-related 7 (yeast) 4.39 4.41 0.027
Foxo3 Forkhead box O3 7.57 7.56 0.004
Hdac6 Histone deacetylase 6 8.01 8.01 0.006
Nbr1 Neighbour of Brca1 gene 1 8.55 8.35 0.204
Ndp52 Nuclear domain 10 protein 52 3.21 2.11 1.099
Genes with protease activity
Atg4b Autophagy-related 4B (yeast) 7.09 7.09 0.001
Atg4d Autophagy-related 4D (yeast) 5.42 5.39 0.023
B. Genes of the autophagy regulatory network
Regulatory genes in autophagy and apoptosis
Atg12 Autophagy-related 12 (yeast) 5.41 5.36 0.053
Atg5 Autophagy-related 5 (yeast) 6.79 6.79 0.001
Bad Bcl-associated death promoter 7.02 7.03 0.010
Bak1 Bcl2-antagonist/killer 1 3.43 3.42 0.010
Bax Bcl2-associated X protein 8.09 8.08 0.004
Bcl2 B-cell leukemia/lymphoma 2 5.06 5.02 0.033
Becn1 Beclin 1 7.16 7.16 0.006
Bid BH3 interacting domain death agonist 4.87 4.87 0.004
Casp3 Caspase 3 7.73 7.68 0.041
Casp8 Caspase 8 7.12 6.89 0.227
Ctsb Cathepsin B 8.48 8.45 0.031
Dapk1 Death associated protein kinase 1 7.79 7.79 0.005
Fadd Fas TNFRSF6-associated via death domain 6.11 6.05 0.059
Mapk8 Mitogen activated protein kinase 8 6.74 6.73 0.007
Pik3c3 Phosphoinositide-3-kinase, class 3. Vps34 6.80 6.80 0.008
Pik3cg Phosphoinositide-3-k catalytic g polypeptide 3.48 3.37 0.111
Sqstm1 Sequestosome 1 9.67 9.67 0.002
Uvrag UV radiation resistance associated gene 7.70 7.48 0.219
Regulatory genes in autophagy and cell cycle
Cdkn1b Cyclin-dependent kinase inhibitor 1B (P27) 5.70 5.73 0.030
Cdkn2a Cyclin-dependent kinase inhibitor 2A 3.74 3.56 0.175
Eif4ebp1 Eukaryotic translation initiation factor 4Ebp1 7.04 7.04 0.006
Eif2ak4 Eukaryotic translation initiation factor 2ak4 6.05 6.32 0.278
Ulk1 Unc-51 like kinase 1 (C. elegans) 6.28 6.22 0.057
Autophagy regulatory genes in other cellular networks
Ctsd Cathepsin D 9.95 9.95 0.001
Ctss Cathepsin S 7.71 7.71 0.000
Mapk14 Mitogen activated protein kinase 14 5.26 5.13 0.131
Pik3r4 Pik3 regulatory subunit polypeptide 4. Vps15 7.53 7.52 0.007
Rps6kb1 Ribosomal protein S6 kinase, polypeptide 1 6.08 6.05 0.028
Tlr1 Toll-like receptor 1 1.42 3.04 1.615
Tlr6 Toll-like receptor 6 3.49 1.17 2.314
Autophagy induction by intracellular pathogens
Eif2ak3 Eukaryotic translation initiation factor 2ak3 7.29 7.21 0.082
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Table 1 (continued )
Gene symbol Gene Igf1þ/þ expression Igf1/ expression Fold change
Ifng Interferon gamma 0.48 0.49 0.005
Lamp1 Lysosomal membrane glycoprotein 1 10.51 10.51 0.003
The cochlear transcriptomes of both genotypes were studied using GeneChip® Mouse Genome 430A2.0 Arrays (Affymetrix, Santa Clara, CA), a whole mouse genome
expression array with a coverage of over 39,000 transcripts. Autophagy genes were identiﬁed and classiﬁed according to their biological function in A) Autophagy machinery
genes and B) Regulation of autophagy genes. A probabilistic framework method (PPLR), which reduces the number of false positives in the estimation of differentially
expressed genes, was used to calculate expression levels of selected genes which are shown as fold change (FC; Igf1/minus Igf1þ/þ expression levels) as reported (Sanchez-
Calderon et al., 2010).
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2008).3.2. Lifelong expression of autophagy and IGF system genes in the
Igf1/ mouse cochlea
Next we studied the time course of the expression of the key
autophagy genes Atg4b, Atg5, Atg9a and Becn1 (Fig. 1A) from E18.5
to P0, P30e60, P270 and P365 ages in cochleae (Fig. 1B). qRT-PCR
conﬁrmed RNA array data and showed that Atg4b, Atg5, Atg9a
and Becn1 are equally expressed in the E18.5 cochlea of both ge-
notypes. Gene expression studies showed a similar time course in
both genotypes. Interestingly, a signiﬁcant increase of around 2-
fold in Becn1 and 4.5-fold in Atg9a transcripts was observed from
the age of P30 onwards, when compared with the perinatal ages
E18.5 and P0, which showed similar expression levels. Atg4b, Atg5
mRNA levels followed a similar pattern in the cochlea although
with lower increases (around 1.5-fold) than those observed in
Becn1 and Atg9a expression. Although there were no signiﬁcant
differences among the genotypes studied, P270 cochleae showed a
greater dispersion in null mice values than those observed in wild
type mice at any age (data not shown). These results suggest the
presence of two subpopulations in nine-month old (P270) null
mice; thus, 3/6 null mice showed increased Atg4b, Atg5 and Becn1
expression as compared to wild type mice. Dispersion preceded a
signiﬁcant decrease of around 0.5-fold in Becn1, Atg4b, Atg5 in P365
cochleae. P365 null mice cochleae showed a statistically signiﬁcant
decrease when compared to null P270 but not with respect to P365
wild type cochleae (Fig. 1B). Thus, these data show that autophagy
gene expression is regulated throughout cochlear maturation and
ageing.
Temporal expression proﬁles of the genes coding for IGF system
elements, Igf1r, Igf2 and Ins2, and inﬂammation-associated cyclo-
oxygenase 2 (Cox2), were studied in cochlea from E18.5, P30e60,
P270 and P250 mice (Table 2). Wild type mouse cochleae showed a
signiﬁcant decrease over the natural life of Igf1r (0.79-, 0.56- and a
0.12-fold decrease between E18.5 and P30e60, P270 or P365,
respectively) and lower expression levels than in adult null mouse
cochleae (Table 2). Igf2 expression remained high during develop-
ment and dropped dramatically after birth in the wild type cochlea
(0.07, 0.05 and 0.01-fold between E18.5 and P30e60, P270 or P365,
respectively.) Igf2 expression levels showed statistically signiﬁcant
differences between wild type and mutant mice at P270 (Table 2).
Ins2 was not detected at any of the time points studied.
To explore if activity-associated inﬂammation could be one of
the stimuli triggering autophagy in the cochlea, we studied the
time course of Cox2 expression, an enzyme of the inﬂammatory
cascade whose participation has been reported in autophagy
(Ricciotti and FitzGerald, 2011). Indeed, Cox2 transcripts showed
parallel temporal proﬁles to those of autophagy genes. Cox2expression levels showed a signiﬁcant 1.5-fold increase in P0
compared to E18.5 cochlea. When both stages, E.18.5 and P0, were
compared to adult P30-6, P270 and P365 cochleae, 0-, 9-, 14- and 5-
fold increases were observed in the adult with respect to perinatal
cochleae. Statistically signiﬁcant differences were observed be-
tween genotypes in P365 mice (Table 2). These data show that
during cochlear maturation and ageing there is a decrease in the
expression of IGF system genes that is concomitant with the in-
crease in inﬂammatory mediators and autophagy gene transcripts.
3.3. Autophagy machinery genes Becn1, Atg4b and Atg5 are
expressed in the vestibule and brain of Igf1þ/þ and Igf1/ mice
The time course of Atg4b, Atg5 and Becn1 expressionwas studied
from E18.5, P0, P30/60 and P270 mice vestibule and brain ho-
mogenates (Fig. 2). Expression levels in cochlear nuclei were also
determined at the age of P150 (Fig. 2A, striped bottom bars).
Similarly to what was found in cochlea, a signiﬁcant increase in
Becn1, Atg4b and Atg5 transcripts was shown in the vestibule
associated with age (Fig. 2). There were no differences among ge-
notypes from E18.5 to P60, but the P270 Igf1/ mouse vestibule
showed a signiﬁcant increase in expression of the three genes
compared to the wild type samples. These data taken together
suggest that autophagy rises in the adult inner ear from P0 to nine
months.
We used a homogenate of whole brain as the neural tissue of
reference and no striking differences could be observed among ages
or genotypes (Fig. 2). To speciﬁcally evaluate the central auditory
pathway, the cochlear nuclei were dissected and gene expressions
compared between P150 Igf1/ and Igf1þ/þ mice (Fig. 2, striped
bars, bottom). In this brain portion, a signiﬁcant increase in Becn1
and Atg5 expression levels was found between null and wild type
mice.
Finally, a global analysis was conducted to compare autophagy
gene expression in three organs (cochlea, vestibule and brain) of
two genotypes (wild type and null mice) at four ages (E18.5, P0,
P30e60 and P270). Becn1, Atg4b and Atg5 expression levels were
signiﬁcantly different between organs; the lowest expression levels
were observed in the vestibule. The cochlea and brain showed a 1.5-
and 2-fold increase with respect to the vestibular tissue, respec-
tively. Postnatal ages P30e60 and P270 showed a signiﬁcant in-
crease of approximately 1.5-fold in gene expression when
compared to the perinatal ages E18.5 and P0 in the three organs
studied. No statistically signiﬁcant differences between genotypes
were obtained (data not shown).
3.4. Autophagic ﬂux is modulated with age in the mouse inner ear
In addition to studying gene expression, we wanted to know if
there was an increase of autophagic ﬂux in the inner ear with age.
Fig. 1. Autophagy machinery genes Becn1, Atg4b, Atg5 and Atg9a are expressed in the cochlea of Igf1þ/þ and Igf1/ mice. (A) Simpliﬁed overview of the factors involved in
autophagosome formation. Growth factor deprivation, inﬂammation or nutrient starvation regulates the activation of the ULK1/2 complex which phosphorylates and activates the
PI3K complex III (PI3KC). The ATG9 cycling system provides a membrane to the developing autophagosome from different donor sources. Autophagosome formation also requires
the action of two Ubiquitin-like (Ubl) systems, ATG8-Ubl and ATG12-Ubl for the elongation and completion of the autophagosome. LC3 is converted into the cytosolic form, LC3-I, by
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Table 2
Time course of expression of IGF system genes and Cox2.
Age (days) Gene symbol Fold change qRT-PCR
E18.5 Igf1r 1.09 ± 0.09
Igf2 0.62 ± 0.02
Ins2 ND
Cox2 0.90 ± 0.08
P30e60 Igf1r 2.06 ± 0.16*
Igf2 2.98 ± 0.68
Ins2 ND
Cox2 1.15 ± 0.35
P270 Igf1r 2.88 ± 0.21**
Igf2 2.84 ± 0.57*
Ins2 ND
Cox2 1.92 ± 0.16
P365 Igf1r 0.72 ± 0.18
Igf2 0.81 ± 0.26
Ins2 ND
Cox2 0.47 ± 0.07*
Expression levels of Igf1r (insulin-like growth factor 1 high afﬁnity receptor), Igf2
(insulin-like growth factor 2), Ins2 (insulin 2) and Cox2 (cyclooxygenase 2) genes in
E18.5, P30e60, P270 and P365 wild type and null mice were compared using qRT-
PCR. Gene-expression values were calculated as 2DDCt. Data are expressed as the
fold-change (FC) ±SEM of the level in null versus wild type mice. Samples of at least
three mice of each genotype were evaluated in triplicate. *P < 0.05 versus wild type
and **P < 0.01 versus wild type. ND: Not detected.
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compared between perinatal (E18.5) and adult (P270) ages in the
cochlea, vestibule and brain (Fig. 3). LC3-II relative levels were
signiﬁcantly increased by 2-fold with age and concomitantly,
SQSTM1/p62 protein levels decreased in the cochlea (Fig. 3A).
Although the adult Igf1/ vestibule showed a signiﬁcant increase
in the LC3-II relative levels, there were no signiﬁcant differences in
LC3-II relative levels with age in the wild type vestibule and brain
(Fig. 3B and C, respectively). SQSTM1/p62 levels showed a decrease
in all the tissues tested although of different magnitudes when
adult and perinatal ages were compared (Fig. 3AeC). There were no
noticeable differences between genotypes at any age (Fig. 3).3.5. Autophagy is abundant in spiral ganglion neurons
Detection of LC3B was carried out in frozen sections of E18.5-
P90 cochleae from wild type and null mice (Fig. 4). LC3B (green)
labelling was localized in the spiral ganglion (Fig. 4A, D, G and J,
asterisks). SOX2 labelling (red) was used to visualize glial cells,
conﬁrming that LC3B positive labelling was associated with neu-
rons. LC3B localization is typically displayed as brighter punctate
labelling throughout the cytoplasm when autophagy is activated
(Koike et al., 2005). Embryonic neurons showed dispersed and low
intensity labelling (Fig. 4B, C, H and I). In contrast, P30e90 spiral
ganglion neurons showed a bright punctate cytoplasm (Fig. 4E, F, K
and L). LC3B labelling intensity quantiﬁcation (Fig. 4M) conﬁrmed
its increase in adult cochlea. No signiﬁcant differences were found
between genotypes at any age.cleavage of ATG4B, and into the membrane associated form, LC3-II, by conjugation with pho
SQSTM1/p62 (p62) binds to ubiquitinated proteins and conducts them to the autophagosom
mice were used to determine cochlear expression levels of Becn1, Atg4b, Atg5 and Atg9a by u
mice of each genotype were studied at the ages indicated. Data from triplicate samples were
differences was evaluated using Student's t-test. Data were compared to wild type mice of di
E18.5, #P < 0.05, ##P < 0.01 and ###P < 0.001 versus P0, ÇP<0.05 versus P30e60, þP < 0.05 ve
^^ P < 0.01 and ^^ ^P < 0.001 versus E18.5, $P < 0.05, $$P < 0.01 and $$$P < 0.001 versus P0, aP<
day and P postnatal day.4. Discussion
In this work we show that the molecular machinery of auto-
phagy is expressed and active in the inner ear from perinatal
stages to adult mice. Increased transcription of Atg genes has been
reported during Drosophila development (Lee et al., 2003) and also
in mice under stressful conditions (Kouroku et al., 2007; Seiliez
et al., 2010). Here we show that Becn1, Atg4b, Atg5 and Atg9
genes are expressed in the inner ear and up-regulated from
perinatal (E18.5 and P0) to adult ages (P30e60 and P270) as the
postnatal inner ear gains functional maturity. Autophagy was
induced in several mouse tissues immediately after birth (Kuma
et al., 2004), however no signiﬁcant differences were found in
cochlear and vestibular expression of ATG coding genes between
E18.5 and P0. On the contrary, up-regulation occurs later, from P30
onwards. Autophagy acts as a source of energy during the peri-
natal period and accordingly, Atg5, Atg7, Atg9 and Atg16 mutant
mice die shortly after birth and exhibit reduced levels of amino
acids in blood and adipose tissue (Kuma et al., 2004). Autophagy
could be operational even without evident up-regulation of Atg
genes (Martinet et al., 2006). Therefore, our results do not exclude
a role for autophagy during early inner ear development; quite the
opposite, it seems to be an important on-going process consid-
ering the wide variety of autophagy genes that are signiﬁcantly
expressed in the E18.5 cochlea. In fact, an even earlier expression
can be envisioned as it plays fundamental roles in the chicken otic
vesicle (Aburto et al., 2012b).
Our results show signiﬁcant up-regulation of the autophagy
machinery between P0 and P30 which suggests that it plays a role
in the onset of inner ear function. Indeed the auditory receptor
starts its functional maturation at P14 and completes it at P30
(Rueda et al., 1996). Furthermore, autophagy is maintained at an
elevated level in young adult mice to later decrease with age as the
results from one-year-old mice suggest. With age, inﬂammation
increases, proteostasis is impaired and requirements for cell
maintenance mechanisms increase (Lopez-Otin et al., 2013). In this
context, increasing autophagy would contribute to maintaining
adult hearing, an idea supported by the fact that otic injury also
increases autophagy (Taylor and Kirkegaard, 2008). The lifespan of
Igf1 null mice is one year, during which time mice show profound
hearing loss, spiral ganglion degeneration and damaged stria vas-
cularis (Riquelme et al., 2010). General cochlear failure is
concomitant with a decrease in the expression of autophagy ma-
chinery genes, which can be either a cause or a consequence of the
cochlear phenotype.
Conclusions obtained from gene expression data were
conﬁrmed by analysis of autophagic proteins. Thus at P270, as
compared to E18.5, cochlea and vestibule showed increased LC3-II
fragment content concomitant with decreased SQSTM1/p62 levels,
which together are an indicator of autophagy induction (Bjorkoy
et al., 2009; Klionsky et al., 2008). SQSTM1/p62 levels signiﬁ-
cantly decreased in all tissues and genotypes studied at P270,
whereas LC3-II relative levels showed a trend to increase in wild
type vestibule and in brain from both genotypes. LC3-II relative
levels can be easily affected by several factors (Mizushima andsphoethanolamine by ATG5 (and the remaining components of the ATG12-Ubl system).
e (Adapted from Aburto et al.,; 2012). (B) Wild type (blue bars) and null (orange bars)
sing qRT-PCR. 18s RNA was used as the endogenous control gene. Samples from 3 to 6
normalized to E18.5 levels and expressed as mean ± SEM of 2DDCt. The signiﬁcance of
fferent ages with the following signiﬁcance *P < 0.05, **P < 0.01 and ***P < 0.001 versus
rsus P270. Comparison to null mice data rendered the following signiﬁcance: P^ < 0.05,
0.05 and aaP<0.01 versus P30e60, &&P < 0.01 versus P270. Abbreviations: E embryonic
Fig. 2. Autophagy machinery genes Becn1, Atg4b and Atg5 are expressed in the vestibule and brain of Igf1þ/þ and Igf1/mice. Wild type (blue bars) and null (orange bars) mice were
used to determine the expression levels of Becn1, Atg4b and Atg5 in the vestibule, homogenate brain and cochlear nuclei (striped bars) by using qRT-PCR. 18s RNA was used as the
endogenous control gene. Samples from 3 to 6 mice of each genotype were studied at the ages indicated. Data from triplicate samples were normalized to E18.5 levels and expressed
as mean ± SEM of 2DDCt. The signiﬁcance of differences was evaluated using Student's t-test. Data were compared to wild type mice of different ages with the following signiﬁcance
*P < 0.05, **P < 0.01 and ***P < 0.001 versus E18.5, #P < 0.05, ##P < 0.01 and ###P < 0.001 versus P0, &P < 0.05 and &&P < 0.01 versus P30e60, ÇP<0.05 versus P150, þP < 0.05 and
þþP < 0.01 versus P270. Comparison with the null mice data rendered the following signiﬁcance: ^P < 0.05, ^^ P < 0.01 and ^^ ^P < 0.001 versus E18.5, $P < 0.05, $$P < 0.01 and
$$$P < 0.001 versus P0. Abbreviations: E embryonic day and P postnatal day.
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observed in cochlear sections by immunostaining. Positive staining
for LC3B formed granular structures in the soma of spiral neurons at
P30 and onward but not at E18.5, where the staining was diffuse.
These results conﬁrm the presence of autophagosomes at P30
(Koike et al., 2005).
It has been proposed that neurons show high levels of auto-
phagy due to their reduced or absent renovation rate to reduce
oxidative species, inﬂammation, damaged organelles and protein
aggregates that would otherwise be deleterious (Damme et al.,
2014; Son et al., 2012). In this regard, our data suggest that the
activation of the hearing receptor and, consequently, the increased
activity of the afferent neurons are stimuli that trigger cochlear
autophagy. Autophagy in the vestibule has additional functions in
otoconial biogenesis (Marino et al., 2010) which may explain why
autophagy genes in the vestibule showed greater up-regulation
than those in the cochlea.
IGF-1 regulates autophagy in different contexts, sometimes with
opposite actions depending on the cell type and situation, therefore
its role is not well-deﬁned yet (Renna et al., 2013; Wang et al.,
2014). Our results indicate that tissues from Igf1/ mice show
mostly the same temporal expression proﬁles as those obtainedfromwild type mice. We did not observe any consistent differences
between genotypes except in vestibules of P270 Igf1/mice where
Becn1, Atg4b and Atg5 levels were higher than in Igf1þ/þ mice. In
addition, no signiﬁcant differences between genotypes were
observed in the autophagic ﬂux measured by LC3-II and SQSTM1/
p62 levels. Although our data suggest that IGF-1 does not play a key
role in the control of autophagy, the deﬁciency of this factor in the
cochlea might be partly compensated. Indeed, IGF-1 deﬁciency in
the cochlea is compensated at its receptor level by the actions of
other insulin family factors (Sanchez-Calderon et al., 2010). How-
ever, the deﬁciency is not fully compensated by that and IGF-1
absence causes a pro-inﬂammatory state, which might be
revealed by the differential regulation of the toll-like receptor
family observed in the Igf1/ cochlea, and which add to those
upstream of Cox2 induction but which autophagy resolves. Inhibi-
tion of downstream insulin/IGF-1 signalling in certain species has
been associated with expanded lifespans and reduced neuro-
degeneration (Cohen et al., 2009; Holzenberger et al., 2003). In
contrast, the broadest understanding is that maintenance of IGF-1
levels is of central importance for neuronal survival during ageing
and accelerated degeneration (Muller et al., 2012; Trueba-Saiz et al.,
2013). This paradox could be due to the fact that IGF-1 actions are
Fig. 3. Autophagy ﬂux increases with age in the mouse inner ear. Levels of the LC3-II/LC3-I ratio and SQSTM1/p62 (p62) of E18.5 and P270 wild type and null mice cochlea (A),
vestibule (B) and brain (C) were determined by Western blotting. SQSTM1/p62 was normalized to b-actin levels. A representative blot of samples obtained from 3 to 6 mice from
each age and genotype are shown. Average values were calculated from densitometric measurements, compared to the E18.5 wild type and plotted in the graph bars to the right
(wild type mice, blue bars, and null mice, orange bars). Results were expressed as the mean ± SEM. The signiﬁcance of the differences was evaluated using Student's t-test. *P < 0.05
and ***P < 0.001 versus E18.5 wild type; ^P < 0.05, ^^ P < 0.01 and ^^ P^ < 0.001 versus E18.5 knockout.
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bolic actions to long-term proliferation, survival and even differ-
entiation. Therefore, the outcome of IGF-1 actions could even be
divergent, depending on the physiopathological context (Varela-
Nieto et al., 2013).5. Conclusions
Our results show that autophagy machinery genes are
expressed throughout the natural life of mice in their cochlea andvestibule. Autophagy gene expression is up-regulated, concurring
with the onset of functional activity. There is effective autophagic
ﬂux in the inner ear from the ﬁrst month of life, and LC3B
expression is intense in spiral ganglion neurons. These data suggest
that autophagy is a housekeeping mechanism necessary for spiral
neuron activity. Chronic IGF-1 deﬁciency caused by the deletion of
the Igf1 gene did not show any evident impact in the expression
pattern of autophagy genes over time. However, a role for IGF-1 in
this process cannot be ruled out as null mice up-regulate
compensatory IGF system elements.
Fig. 4. Autophagy is localized in the neurons of the spiral ganglion. Immunostaining for LC3B showed localization of autophagy in the spiral ganglion neurons (A, D, G and J;
asterisks show the area enlarged in B, E, H, and K, respectively). LC3B subcellular localization was evident in the neuronal cytoplasm (B, E, H and K; dotted white squares show
the area enlarged in C, F, I and L, respectively). In C, F, I and L, selected neurons are circled for comparison. SOX2 staining of glial cells is shown in red (AeL). E18.5 wild type and null
mice cochlea showed diffuse LC3B labelling in the cytoplasm (green, B, C, H and I). P90 wild type and null mouse cochleae presented a bright punctate LC3B labelling (green, E, F, K
and L). Intensity of LC3B immunoﬂuorescence in spiral ganglion was quantiﬁed using ImageJ software (M). Data were obtained from 4 to 12 sections from at least 3 mice of each age
and genotype and are shown relative to those of E18.5 wild type mice as mean ± SEM. The signiﬁcance of the differences was evaluated using Student's t-test: *P < 0.05 versus E18.5
wild type. Scale bars: 25 mm (A, D, G and J), 10 mm (B, C, E, F, H, I, K and L).
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